Our proprietary PAIR technology is designed to address inflammation further upstream, reducing the cascade of damage before it begins. By targeting inflammation at its source through dual mechanisms ...
Findings highlight PL9654 and PL9655's potential to treat diabetic retinopathy through inflammation resolution, vascular stabilization, and neuroprotection PL9654 and PL9655 down-regulate inflammatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback